Best Folate Analog Metabolic Inhibitor for esophageal neoplasms
5 Folate Analog Metabolic Inhibitor drugs indicated for esophageal neoplasms, ranked by our independent rating. The current highest-rated is xatmep. Compare them with all treatments for esophageal neoplasms or the full Folate Analog Metabolic Inhibitor class. Not medical advice — always consult a professional.
Top folate analog metabolic inhibitor for esophageal neoplasms: 1. Xatmep · 2. Methotrexate Preservative Free · 3. Methotrexate Lpf
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Xatmep | 72/100 | Prescription | $5 | View → |
| 2 | Methotrexate Preservative Free | 42/100 | Prescription | $5 | View → |
| 3 | Methotrexate Lpf |
Full ranking · 5 drugs
Frequently asked
- What is the best folate analog metabolic inhibitor for esophageal neoplasms?
- By our independent rating, xatmep currently ranks highest among Folate Analog Metabolic Inhibitor drugs used for esophageal neoplasms. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which folate analog metabolic inhibitor drugs treat esophageal neoplasms?
- pharmaranks lists 5 Folate Analog Metabolic Inhibitor products indicated for esophageal neoplasms, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.